Home
>
National Drug Code (NDC)
>
Santalia Clinical Intenstive Spot Treatment
Santalia Clinical Intenstive Spot Treatment - 76358-192-03 - (Salicylic Acid)
Drug Information of Santalia Clinical Intenstive Spot Treatment
| Product NDC: | 76358-192 |
| Proprietary Name: | Santalia Clinical Intenstive Spot Treatment |
| Non Proprietary Name: | Salicylic Acid |
| Active Ingredient(s): | 2.18 g/100mL & nbsp; Salicylic Acid |
| Administration Route(s): | TOPICAL |
| Dosage Form(s): | GEL |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Santalia Clinical Intenstive Spot Treatment
| Product NDC: | 76358-192 |
| Labeler Name: | Santalis Pharmaceuticals |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | part333D |
| Marketing Category: | OTC MONOGRAPH FINAL |
| Start Marketing Date: | 20130101 |
Package Information of Santalia Clinical Intenstive Spot Treatment
| Package NDC: | 76358-192-03 |
| Package Description: | 2 mL in 1 PACKET (76358-192-03) |
NDC Information of Santalia Clinical Intenstive Spot Treatment
| NDC Code | 76358-192-03 |
| Proprietary Name | Santalia Clinical Intenstive Spot Treatment |
| Package Description | 2 mL in 1 PACKET (76358-192-03) |
| Product NDC | 76358-192 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | Salicylic Acid |
| Dosage Form Name | GEL |
| Route Name | TOPICAL |
| Start Marketing Date | 20130101 |
| Marketing Category Name | OTC MONOGRAPH FINAL |
| Labeler Name | Santalis Pharmaceuticals |
| Substance Name | SALICYLIC ACID |
| Strength Number | 2.18 |
| Strength Unit | g/100mL |
| Pharmaceutical Classes |
